TCL Archive NCI Considers Seeking New Study Section For Clinical Research, Or Expansion Of E2 November 23, 1990
TCL Archive Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report September 23, 1988
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014